Sponsors: DemeRx IB, Inc. (atai Life Sciences); MAC Clinical Research; ERT: Clinical Trial Technology Solutions

More Info | Enrol

Following a successful medical screen and upon review of medical history, a minimum of 30 healthy volunteers who have previously tried a hallucinogen will take a single oral dose of Ibogaine in a clinical setting and stay for 6 nights in the clinic.

You will attend 4 screening visits to qualify for the study. After treatment you will attend 4 brief out-patient visits at the MAC Greater Manchester Clinic.

Your involvement in the study will be completed within 2 months.

Reimbursement: £2,045 in cash plus reasonable travel expenses or transport provided.

KEY INCLUSION CRITERIA

  • Males and Females (post-menopausal or surgically sterile)
  • Age 18 – 55
  • Normal Weight
  • Past recreational drug use including hallucinogens (MDMA, LSD or Psilocybin)

KEY EXCLUSION CRITERIA

  • Dependency on drug (excluding caffeine) or alcohol
  • History of seizures or convulsions
  • History of heart disease or current hypertension meds
  • Heavy smokers or vapers
  • Current or ongoing COVID-19 infection or long COVID syndrome

Other eligibility criteria will apply. Please contact MAC for more information.

If you are eligible you will receive a comprehensive health screen

More Info | Enrol

Information retrieved from researchforyou.co.uk